United Therapeutics CFO sells 10,000 shares after option exercise
United Therapeutics CFO and Treasurer James Edgemond reported an exercise-and-sell transaction in company common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
United Therapeutics CFO and Treasurer James Edgemond reported an exercise-and-sell transaction in company common stock. On May 11, he exercised stock options for 10,000 shares at $135.42 per share and sold 10,000 shares in multiple open-market trades around the $570–$580 range under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he directly holds 18,876 shares of common stock and 12,500 stock options.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($4.38M approx. pre-tax spread)
Exercise and Sale
14 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.73M)
Approx. gross sale proceeds
$5.73M
Approx. exercise cost
$1.35M
Approx. pre-tax spread
$4.38M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $135.42 | $1.35M |
| Sale | Common Stock | 1,289 | $569.4644 | $734K |
| Sale | Common Stock | 2,059 | $570.1745 | $1.17M |
| Sale | Common Stock | 1,496 | $571.4247 | $855K |
| Sale | Common Stock | 1,356 | $572.3224 | $776K |
| Sale | Common Stock | 480 | $573.2232 | $275K |
| Sale | Common Stock | 661 | $574.5744 | $380K |
| Sale | Common Stock | 530 | $575.264 | $305K |
| Sale | Common Stock | 89 | $576.6812 | $51K |
| Sale | Common Stock | 893 | $577.589 | $516K |
| Sale | Common Stock | 476 | $578.4229 | $275K |
| Sale | Common Stock | 591 | $579.7969 | $343K |
| Sale | Common Stock | 80 | $580.45 | $46K |
Holdings After Transaction:
Stock Option — 12,500 contracts (Direct);
Common Stock — 18,876 shares (Direct)
Footnotes (12)
- F1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F10. This transaction was executed in multiple trades at prices ranging from $577.09 to $578.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $578.09 to $578.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $579.11 to $580.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. This transaction was executed in multiple trades at prices ranging from $568.87 to $569.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $569.87 to $570.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $570.89 to $571.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $571.89 to $572.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $572.97 to $573.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $574.04 to $574.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $575.04 to $575.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $576.07 to $577.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Sale price (example high): $580.45 per share
Sale price (example range low): $568.87–$569.86
+5 more
8 metrics
Shares sold
10,000 shares
Total common shares sold in open-market transactions on May 11
Sale price (example high)
$580.45 per share
One reported weighted average sale price for a trade batch
Sale price (example range low)
$568.87–$569.86
Price range for one set of multiple trades
Options exercised
10,000 shares
Common shares acquired via stock option exercise
Option exercise price
$135.42 per share
Strike price of exercised stock options
Shares held after
28,876 shares
Direct common stock ownership following transactions
Options held after
12,500 options
Stock options remaining after the reported exercise
Net share change
10,000 shares
Net-sell shares per transaction summary
Key Terms
Rule 10b5-1 trading plan, stock options, derivative security, weighted average price, +1 more
5 terms
Rule 10b5-1 trading plan financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan..."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did United Therapeutics (UTHR) report for James Edgemond?
United Therapeutics reported that CFO and Treasurer James Edgemond exercised options for 10,000 common shares and sold 10,000 shares in open-market transactions. These trades occurred on May 11 under a pre-arranged Rule 10b5-1 trading plan, according to the Form 4 filing.
What stock options did the United Therapeutics (UTHR) CFO exercise in this Form 4?
James Edgemond exercised stock options covering 10,000 shares of United Therapeutics common stock. The options carried an exercise price of $135.42 per share, with an original expiration date in March 2027, as reflected in the derivative transaction reported in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
